# FDA 483 - Silliker Laboratories Group, Inc - June 30, 2025

Source: https://www.keypedia.com/records/483/silliker-laboratories-group-inc/d625a6b5-76ad-401d-844a-01868249279b

> FDA 483 for Silliker Laboratories Group, Inc on June 30, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Silliker Laboratories Group, Inc
- Inspection Date: 2025-06-30
- Product Type: drugs
- Office Name: Los Angeles District Office
- Summary: Silliker, Inc. in Cypress, CA, a control testing laboratory, was issued a Form 483 with three observations following an FDA inspection. The inspection revealed significant deficiencies in the quality control unit's adherence to procedures, inadequate calibration and qualification of laboratory equipment, and a lack of documented verification for drug product sample testing methods. These issues indicate a concerning lack of control over critical laboratory processes.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/michael-araneta/c94c95f4-2cda-43f5-a02a-2b5d82fe2c7d)
- [issuing_officer](https://www.keypedia.com/people/ngozi-g-offor/d9d0aa28-6bd1-4427-a712-8716c96b1f3d)

Company: https://www.keypedia.com/companies/silliker-laboratories-group-inc/a9d53aca-972c-488b-a699-d41cdadcf067

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b